chartexchange

REVB
Revelation Biosciences, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 1:36:27 PM EST
4.28USD-2.397%(-0.10)6,580
Pre-marketNov 13, 2026 8:59:30 AM EST
4.20USD-4.110%(-0.18)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$4.38
Beta
2.77
52-Week High
$5.80 2026-01-23
52-Week Low
$0.47 2026-10-16
SMA 50
$2.01
SMA 200
$1.37
Avg. Vol 10D
15,123
Avg. Vol 30D
49,854
Avg. Vol 90D
42,089
Relative Vol
0.13
569,059
435,199
63.5600%
5,450
Jan 28, 2026 · 1-for-4 (reverse)
REVB Profile

we develop immunologic therapeutics and diagnostics designed to make the world a healthier place

REVB Performance
PeriodPriceDateChangeBeta
1W3.892026-11-06+7.20%3.597
1M0.732026-10-13+471.08%10.814
3M1.112026-08-13+275.68%7.557
6M1.052026-05-13+297.14%4.203
1Y3.652025-11-13+14.28%2.772
2Y174.722024-11-13-97.61%—
5Y1,715,616.002022-01-11-100.00%1.345
REVB Stock Summary

Revelation Biosciences, Inc. Common Stock (NASDAQ:REVB) stock price today is $4.17, and today's volume is 6,580. REVB is down 4.795% today. The 30 day average volume is 49,854. REVB market cap is $2.37M with 569,059 shares outstanding.